Physiotherapy management in late-onset Pompe disease: Clinical practice in 88 patients

Molecular Genetics and Metabolism

Volumn 107, Issue 1-2, 2012, Pages 111-115

  Favejee, Marein M ^a   Huisstede, Bionka M A ^a   Bussmann, Johannes B J ^a   Kruijshaar, Michelle E ^a,b   van der Ploeg, Ans T ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Exercise therapy; Physical therapy management; Pompe disease

Indexed keywords

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; CLINICAL PRACTICE; DISEASE DURATION; ENDURANCE TRAINING; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 2; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; PATIENT ATTITUDE; PATIENT REFERRAL; PHYSIOTHERAPIST; PHYSIOTHERAPIST ATTITUDE; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESISTANCE TRAINING; WALKING AID;

ADULT; AGED; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; MALE; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; QUESTIONNAIRES; REFERRAL AND CONSULTATION; TREATMENT OUTCOME;

EID: 84866180315     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.07.014     Document Type: Article

References (14)

1. Van den Hout J.M., Kamphoven J.H., Winkel L.P., Arts W.F., De Klerk J.B., Loonen M.C., Vulto A.G., Cromme-Dijkhuis A., Weisglas-Kuperus N., Hop W., Van Hirtum H., Van Diggelen O.P., Boer M., Kroos M.A., Van Doorn P.A., Van der Voort E., Sibbles B., Van Corven E.J., Brakenhoff J.P., Van Hove J., Smeitink J.A., de Jong G., Reuser A.J., Van der Ploeg A.T. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 2004, 113:e448-e457.
2. Kishnani P.S., Corzo D., Leslie N.D., Gruskin D., Van der Ploeg A., Clancy J.P., Parini R., Morin G., Beck M., Bauer M.S., Jokic M., Tsai C.E., Tsai B.W., Morgan C., O'Meara T., Richards S., Tsao E.C., Mandel H. Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease. Pediatr. Res. 2009, 66:329-335.
3. Kishnani P.S., Corzo D., Nicolino M., Byrne B., Mandel H., Hwu W.L., Leslie N., Levine J., Spencer C., McDonald M., Li J., Dumontier J., Halberthal M., Chien Y.H., Hopkin R., Vijayaraghavan S., Gruskin D., Bartholomew D., van der Ploeg A., Clancy J.P., Parini R., Morin G., Beck M., De la Gastine G.S., Jokic M., Thurberg B., Richards S., Bali D., Davison M., Worden M.A., Chen Y.T., Wraith J.E. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 2007, 68:99-109.
4. Strothotte S., Strigl-Pill N., Grunert B., Kornblum C., Eger K., Wessig C., Deschauer M., Breunig F., Glocker F.X., Vielhaber S., Brejova A., Hilz M., Reiners K., Muller-Felber W., Mengel E., Spranger M., Schoser B. Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial. J. Neurol. 2009, 257:91-97.
5. van Capelle C.I., Winkel L.P., Hagemans M.L., Shapira S.K., Arts W.F., van Doorn P.A., Hop W.C., Reuser A.J., van der Ploeg A.T. Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease. Neuromuscul. Disord. 2008, 18:447-452.
6. van der Ploeg A.T., Clemens P.R., Corzo D., Escolar D.M., Florence J., Groeneveld G.J., Herson S., Kishnani P.S., Laforet P., Lake S.L., Lange D.J., Leshner R.T., Mayhew J.E., Morgan C., Nozaki K., Park D.J., Pestronk A., Rosenbloom B., Skrinar A., van Capelle C.I., van der Beek N.A., Wasserstein M., Zivkovic S.A. A randomized study of alglucosidase alfa in late-onset Pompe's disease N. Engl. J. Med. 2010, 362:1396-1406.
7. Fowler W.M., Taylor M. Rehabilitation management of muscular dystrophy and related disorders: I. The role of exercise. Arch. Phys. Med. Rehabil. 1982, 63:319-321.
8. Cup E.H., Pieterse A.J., Ten Broek-Pastoor J.M., Munneke M., van Engelen B.G., Hendricks H.T., van der Wilt G.J., Oostendorp R.A. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review. Arch. Phys. Med. Rehabil. 2007, 88:1452-1464.
9. Hagemans M.L., Winkel L.P., Van Doorn P.A., Hop W.J., Loonen M.C., Reuser A.J., Van der Ploeg A.T. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005, 128:671-677.
10. Slonim A.E., Bulone L., Goldberg T., Minikes J., Slonim E., Galanko J., Martiniuk F. Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy. Muscle Nerve 2007, 35:70-77.
11. Leutholtz B.C., Ripoll I. The effects of exercise on a patient with severe acid maltase deficiency. Eur. J. Phys. Med. Rehabil. 1996, 6:185-187.
12. Terzis G., Dimopoulos F., Papadimas G.K., Papadopoulos C., Spengos K., Fatouros I., Kavouras S.A., Manta P. Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy. Mol. Genet. Metab. 2011, 104(3):279-283.
13. Martin R.J., Sufit R.L., Ringel S.P., Hudgel D.W., Hill P.L. Respiratory improvement by muscle training in adult-onset acid maltase deficiency. Muscle Nerve 1983, 6:201-203.
14. Jones H.N., Moss T., Edwards L., Kishnani P.S. Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease. Mol. Genet. Metab. 2011, 104(3):417-420.